EnnovaBio

Quick facts

Phase 2 pipeline

• ENN0403 capsules, high dose
• ENN0403 capsules, low dose
  ENN0403 capsules, low dose, is an investigational drug with unknown mechanism of action.
• ENN0403, high dose
  ENN0403 is a high-dose investigational drug with an unknown mechanism of action.
• ENN0403, low dose

Phase 1 pipeline

• ENN0403 20mg
• ENN0403 4mg

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• EnnovaBio portfolio CI brief
• EnnovaBio pipeline updates RSS